We are live on ! Find out more
MBIO icon

Mustang Bio

71 hedge funds and large institutions have $10.3M invested in Mustang Bio in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 15 increasing their positions, 25 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

8.15% less ownership

Funds ownership: 25.38% → 17.23% (-8.1%)

12% less funds holding

Funds holding: 81 → 71 (-10)

39% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 23

40% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 25

68% less capital inflows, than outflows

Capital inflows: $2.88M | Capital outflows: $8.98M

Holders
71
Holders Change
-10
Holders Change %
-12.35%
% of All Funds
1.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
15
Reduced
25
Closed
23
Calls
$61​K
Puts
–
Net Calls
+$61​K
Net Calls Change
+$15​K

MBIO Hedge Fund Activity: Q2 2022 in Review

71 of the 5,965 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q2 2022, worth a combined $10.3M — down 59% from $25.3M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of MBIO and 14 opened new positions — a net loss of 9 holders — while 25 trimmed existing stakes and 15 added.

The largest buyer was Laurion Capital Management, opening a new position worth an estimated $1.07M. The largest seller was BlackRock, cutting an estimated $2.52M.

  • 71 institutional investors held Mustang Bio (MBIO) as of Q2 2022, down from 81 in Q1 2022.
  • Funds reported $10.3M of Mustang Bio stock for Q2 2022, down 59% quarter-over-quarter.
  • 14 funds opened new Mustang Bio positions in Q2 2022 and 23 closed out, a net change of -9 holders.
  • The largest Mustang Bio buyer in Q2 2022 was Laurion Capital Management, an estimated $1.07M added.
  • The largest Mustang Bio seller in Q2 2022 was BlackRock, an estimated $2.52M sold.

Based on aggregated 13F filings for Q2 2022.